Altered expression of microRNAs and B lymphocytes during Natalizumab therapy in multiple sclerosis

Altered expression of microRNAs and B lymphocytes during Natalizumab therapy in multiple sclerosis

MicroRNAs (miRNAs) are a family of non-translated small ribonucleic acids (RNAs) measuring 21–25 nucleotides in length that play various roles in multiple sclerosis (MS). By regulating gene expression via either mediating translational repression or cleavage of the target RNA, miRNAs can alter the e...

Full description

Bibliographic Details
Main Authors: André Eduardo de Almeida Franzoi, Fernanda Subtil de Moraes Machado, Washigton Luiz Gomes de Medeiros Junior, Isabelle Pastor Bandeira, Wesley Nogueira Brandão, Marcus Vinicius Magno Gonçalves
Format: Article
Language:English
Published: Elsevier 2021-06-01
Series:Heliyon
Subjects:
MicroRNA
Natalizumab
Multiple sclerosis
B lymphocyte
Therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844021013669

Similar Items

Similar Items